AAO: Higher-Dose Injection No Better For Retinal Vein Occlusion

Wednesday, October 28, 2009

medpageToday

Increasing the dose of intravitreal bevacizumab (Avastin) doesn't improve outcomes for central retinal vein occlusion, researchers found.

CareCloud Central
CareCloud Central is a medical practice ... view product
VISUPLAN 500 Non-Contact Tonometer
The measurement of intraocular pressure ... view product

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

AdGlare Leaderboard